Literature DB >> 25089097

Venous thromboembolism in cancer patients: a call for more awareness.

A Delluc1, M Carrier2.   

Abstract

Entities:  

Year:  2014        PMID： 25089097      PMCID： PMC4117613          DOI： 10.3747/co.21.2175

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  10 in total

1.  Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH.

Authors:  M Carrier; A A Khorana; J I Zwicker; S Noble; A Y Y Lee
Journal:  J Thromb Haemost       Date:  2013-09       Impact factor: 5.824

2.  Incidence of venous thromboembolism and its effect on survival among patients with common cancers.

Authors:  Helen K Chew; Theodore Wun; Danielle Harvey; Hong Zhou; Richard H White
Journal:  Arch Intern Med       Date:  2006-02-27

3.  Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer.

Authors:  Marc Carrier; Alok A Khorana; Patricia Moretto; Grégoire Le Gal; Rebecca Karp; Jeffrey I Zwicker
Journal:  Am J Med       Date:  2013-10-05       Impact factor: 4.965

4.  Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines.

Authors:  M Mandalà; A Falanga; F Roila
Journal:  Ann Oncol       Date:  2011-09       Impact factor: 32.976

5.  Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.

Authors:  A A Khorana; C W Francis; E Culakova; N M Kuderer; G H Lyman
Journal:  J Thromb Haemost       Date:  2007-03       Impact factor: 5.824

6.  Evidence-based guidance on venous thromboembolism in patients with solid tumours.

Authors:  M A Shea-Budgell; C M J Wu; J C Easaw
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

Review 7.  Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management.

Authors:  E Donnellan; B Kevane; B R Healey Bird; F Ni Ainle
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

Review 8.  Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

Authors:  Gary H Lyman; Alok A Khorana; Nicole M Kuderer; Agnes Y Lee; Juan Ignacio Arcelus; Edward P Balaban; Jeffrey M Clarke; Christopher R Flowers; Charles W Francis; Leigh E Gates; Ajay K Kakkar; Nigel S Key; Mark N Levine; Howard A Liebman; Margaret A Tempero; Sandra L Wong; Ann Alexis Prestrud; Anna Falanga
Journal:  J Clin Oncol       Date:  2013-05-13       Impact factor: 44.544

9.  Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients.

Authors:  M Carrier; G Le Gal; R Cho; S Tierney; M Rodger; A Y Lee
Journal:  J Thromb Haemost       Date:  2009-02-24       Impact factor: 5.824

10.  Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis.

Authors:  Ryma Ihaddadene; Grégoire Le Gal; Aurélien Delluc; Marc Carrier
Journal:  Thromb Res       Date:  2014-05-02       Impact factor: 3.944
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.